Kenneth W. Rohrbach

Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor

Siew Peng Ho, Lorey K. Takahashi, Valentin Livanov et al. · Molecular Brain Research · 2001 · 80 citations

Factor-2 Receptor, Psychoneuroimmunology, Neuropsychology +14

Cognition enhancement by the acetylcholine releaser DuP 996

Leonard Cook, Victor J. Nickolson, George F. Steinfels et al. · Drug Development Research · 1990 · 63 citations

Neuropsychology, Dup 996, Abstract Dup 996 +26

Discovery of ( <i>R</i> )-9-Ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1- <i>a</i> ]isoindol- 6(2 <i>H</i> )-one, a Selective, Orally Active Agonist of the 5-HT _2C Receptor

Dean A. Wacker, Jeffrey Varnes, Sarah E. Malmstrom et al. · Journal of Medicinal Chemistry · 2007 · 33 citations · Full text

Ibipinabant attenuates <i>β</i> ‐cell loss in male Zucker diabetic fatty rats independently of its effects on body weight

Kenneth W. Rohrbach, Michael A. Thomas, Susan Glick et al. · Diabetes Obesity and Metabolism · 2012 · 32 citations

DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'- oxoethyl)piperidine HBr], a potential antipsychotic agent: preclinical behavioral effects.

Larry L. Cook, S W Tam, Kenneth W. Rohrbach · Journal of Pharmacology and Experimental Therapeutics · 1992 · 23 citations